Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endoscopic drainage treatment of pancreatic pseudocysts.

Hepato-gastroenterology·2014
Same author

Single balloon enteroscopy for endoscopic retrograde cholangiography in patients with Roux-en-Y hepaticojejuno anastomosis.

World journal of gastroenterology·2013
Same author

Unusual Multiorgan Immunoglobulin G4 (IgG4) Inflammation: Autoimmune Pancreatitis, Mikulicz Syndrome, and IgG4 Mastitis.

Gut and liver·2013
Same author

Endoscopic drainage treatment of pancreatic pseudocysts.

Hepato-gastroenterology·2013
Same author

Diagnosis and treatment of autoimmune hepatitis.

Digestive diseases (Basel, Switzerland)·2012
Same author

Immunoglobulin G4-related cholangitis: a variant of IgG4-related systemic disease.

Digestive diseases (Basel, Switzerland)·2012

Related Experiment Video

Updated: May 17, 2026

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
16:19

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

Published on: September 13, 2014

Hepatorenal syndrome.

Jan Lata1

  • 1Department of Internal Medicine, University Hospital and Faculty of Medicine, Ostrava University, 70103 Ostrava, Czech Republic. jan.lata@osu.cz

World Journal of Gastroenterology
|October 11, 2012
PubMed
Summary
This summary is machine-generated.

Hepatorenal syndrome (HRS) is a kidney failure in liver disease patients. Terlipressin plus albumin offers a bridge treatment, but recovery rates are under 50%.

Keywords:
AscitesHepatorenal syndromeLiver cirrhosisTerlipressinVasoconstrictors

Related Experiment Videos

Last Updated: May 17, 2026

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
16:19

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

Published on: September 13, 2014

Area of Science:

  • Gastroenterology and Hepatology
  • Nephrology
  • Critical Care Medicine

Background:

  • Hepatorenal syndrome (HRS) is functional renal failure in patients with liver disease and portal hypertension.
  • It is characterized by morphologically intact kidneys with reduced glomerular filtration and increased tubular resorption, leading to uremia.
  • HRS predominantly occurs in patients with ascites and is classified into Type 1 (acute) and Type 2 (slowly progressive).

Purpose of the Study:

  • To define Hepatorenal Syndrome (HRS) and its underlying pathophysiology.
  • To discuss therapeutic strategies for HRS, focusing on bridge treatments for liver transplant candidates.
  • To evaluate the efficacy and limitations of terlipressin plus albumin in managing HRS.

Main Methods:

  • Literature review and synthesis of existing research on Hepatorenal Syndrome.
  • Analysis of clinical data regarding the use of terlipressin and albumin as a treatment.
  • Discussion of alternative and supportive therapies like transjugular intrahepatic portosystemic shunt.

Main Results:

  • Type 1 HRS results from reduced effective circulating volume due to splanchnic vasodilation and decreased cardiac output.
  • Terlipressin plus albumin is a suitable bridge treatment for HRS patients ineligible for liver transplantation.
  • Renal function recovery is achieved in less than 50% of patients, with potential for recurrence even after initial response.

Conclusions:

  • Liver transplantation remains the most appropriate treatment for HRS, but is not feasible for all patients.
  • Terlipressin combined with albumin shows promise as a bridge therapy, though its success rate is limited.
  • Further research is needed to improve treatment outcomes for Hepatorenal Syndrome.